Neuland Laboratories Limited (NSE: NEULANDLAB)

Market Cap	160.00B
Revenue (ttm)	16.35B
Net Income (ttm)	3.36B
Shares Out	n/a
EPS (ttm)	261.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jul 12, 2024

Volume	81,093
Open	12,713
Previous Close	12,519
Day's Range	11,601 - 12,900
52-Week Range	3,611 - 13,222
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Neuland Laboratories

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1984
• Employees: 1,643
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NEULANDLAB

Financial Performance

In 2023, Neuland Laboratories's revenue was 15.59 billion, an increase of 30.81% compared to the previous year's 11.91 billion. Earnings were 3.00 billion, an increase of 83.51%.